Evidence map›Paper›PMID 42374258›Full record

ArticleBMC gastroenterology2026

Risk score for esophageal and gastric cancer in the over 50-year-old population based on self-reported information -the RISC-GAP project.

Timo Schmitz, Julia Reizner, Sha Sha, Ben Schöttker, Hermann Brenner, David Roser, Helmut Messmann, Christa Meisinger, Jakob Linseisen

Abstract read
In one paragraph

Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Timo SchmitzEpidemiology, Medical Faculty, University of Augsburg, Augsburg, Germany. timo.schmitz@med.uni-augsburg.de.
Julia ReiznerEpidemiology, Medical Faculty, University of Augsburg, Augsburg, Germany.
Sha ShaDivision of Clinical Epidemiology and Early Cancer Detection, German Cancer Research Center, Heidelberg, Germany.
Ben SchöttkerDivision of Clinical Epidemiology and Early Cancer Detection, German Cancer Research Center, Heidelberg, Germany.
Hermann BrennerDivision of Clinical Epidemiology and Early Cancer Detection, German Cancer Research Center, Heidelberg, Germany.
David RoserDepartment of Gastroenterology, University Hospital Augsburg, Augsburg, Germany.
Helmut MessmannDepartment of Gastroenterology, University Hospital Augsburg, Augsburg, Germany.
Christa MeisingerEpidemiology, Medical Faculty, University of Augsburg, Augsburg, Germany.
Jakob LinseisenEpidemiology, Medical Faculty, University of Augsburg, Augsburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim was to build a risk score (RS) for gastric and esophageal cancer (GEC) based on self-reported information as a first step to develop a risk-adapted screening modality for GEC or precursor lesions in a non-high incidence region in the framework of the RISC-GAP project.

methodsData from 375,280 participants aged 50 years and older in the UK Biobank project were used. The outcome was incident esophageal or gastric cancer. Various variables, including sociodemographic data, medical conditions, medication, lifestyle factors and diet, were initially considered. To be able to use the RS as a screening tool in the general population, only variables that can be determined by self-report were selected. For variable selection, we used COX regression models with LASSO penalization; the main criterion was 5- and 10-years AUC.

resultsThe final score included the following eight variables: sex, age, smoking status, drinking status, body mass index, history of esophagitis, medication with gastric acid inhibitors and surgery in the stomach/esophagus area. 10-fold cross-validation revealed a discrimination of 0.740 (5-year AUC) and 0.724 (10-year AUC), respectively. High-risk individuals were defined as those with a 10-year cancer risk of 1% or more (around 6% of the study population).

conclusionThe RS allows a reasonable discrimination of individuals with an elevated risk of gastric or esophageal cancer. In further steps of the RISC-GAP project it will be evaluated whether selection of a high-risk population can be further improved by additional clinical and biomarker information.

Indexed as

Early Detection of CancerEsophageal NeoplasmsSelf ReportStomach NeoplasmsAgedAge FactorsBody Mass IndexFemaleHumansIncidenceMaleMiddle AgedProportional Hazards ModelsRisk AssessmentRisk FactorsSmokingEsophageal cancerGastric cancerRisk scoreScreeningSelf-reported information

Identifiers

PMID42374258
PMCPMC13312655

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.